郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价A comparison of different intensified upstream processes highlighting the advantage of WuXi Biologics' Ultra-high Productivity platform (WuXiUPTM) in improved product quality and purification yield.

期刊：Biotechnology progress发表年份：2024作者：Xiang Zheng; Mingyue Fang; Yanling Zou; Shuo Wang; Weichang Zhou; Hang Zhou
阅读更多 →

药效评价In silico mediated workflow for rapid development of downstream processing: Orthogonal product-related impurity removal for a Fc-containing therapeutic.

期刊：Journal of chromatography. A发表年份：2024作者：Dongyoun Jang; Scott H Altern; Steven M Cramer
阅读更多 →

药效评价Development of a multiplexing method for the quantification of "high-risk" host cell lipases in biotherapeutics by Luminex.

期刊：Analytica chimica acta发表年份：2024作者：Jeremy D Osko; Shannon Rivera; Fengqiang Wang; Thomas Niedringhaus
阅读更多 →

药效评价Applying UHPLC-HRAM MS/MS Method to Assess Host Cell Protein Clearance during the Purification Process Development of Therapeutic mAbs.

期刊：International journal of molecular sciences发表年份：2024作者：Reiko Kiyonami; Rafael Melani; Ying Chen; A I De Leon; Min Du
阅读更多 →